InvestorsHub Logo
Followers 12
Posts 713
Boards Moderated 0
Alias Born 02/09/2018

Re: rushmann post# 207

Tuesday, 04/03/2018 10:43:38 AM

Tuesday, April 03, 2018 10:43:38 AM

Post# of 1011
The VC deal is definitely great, this Malta deal could be more lucrative. Once they get the final gmp cert they can fast track a lot of MJ prescriptions (from what I read). Malta is an opening to Europe. With revenue of $1mil per hundred Cannepil users, and the fact that Cannepil will still be cheaper than other treatments.. I think will be huge.

I was reading about the gmp cert last night. I guess this is a HUGE thing especially in Europe- being the only one (from what I know). This could be even better than the Derma division.

I’ve been accumulating since January, my thought is the same I think we have a couple weeks at this level to accumulate. I think by end of year this should be over .50 (being conservative). I also like that their financing is in the past. They should have revenue to support any projects moving forward